Skip to main content
. Author manuscript; available in PMC: 2025 May 27.
Published in final edited form as: J Med Chem. 2024 Jul 19;67(15):12534–12552. doi: 10.1021/acs.jmedchem.4c00411

Table 4.

EC50 values for prioritized compounds determined in a cellular NanoBRET target engagement assay. See Table S2 for the complete data set. n.d. = not determined.

EC50 [nM]
cpd ID EPHA2 EPHA4 GAK ABL1 FGFR1 FLT1
23 470 ± 31 450 ± 140 20 ± 5.7 27000 ± 210 3100 ± 870 13000 ± 5400
54 370 ± 68 84 ± 32 160 ± 29 2700* 1200 ± 230 13000 ± 130
55 260 ± 73 57 ± 23 27 ± 5.6 >50000 18000 ± 1900 33000 ± 3600
56 440 ± 0.99 250 ± 57 40* 30000 ± 2300 2000* 7500*
58 250* 190 ± 45 n.d. 6400* 470* 1100*
61 340 ± 81 37 ± 12 33 ± 4.9 8400* 7600 ± 1100 17000 ± 2300
75 1600 ± 380 37 ± 12 24 ± 3.4 >50000 34000 ± 11000 42000 ± 5700
78 470* n.d. 30* 17000* n.d. n.d.
79 1400 ± 290 60 ± 13 31 ± 2.9 32000* 9800 ± 1900 23000 ± 2600
LDN-211904 270* 48 ± 6.3 −0.4% binding @ 1 μM 49000* >50000* >50000*
*

Mean of one experiment performed in technical duplicates